BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Terminated 26 enrolled National Cancer Institute (NCI)

NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of BMS-247550 in treating patients who have advanced soft tissue sarcoma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start: 2001-06
Primary completion: 2006-06
Completion: 2006-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ixabepilone	Small molecule	—	Intravenous

BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma

Summary

Timeline

Drugs

Indications